跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Medlosar-Plus 25 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Medlosar-Plus 25
Approved
STANDARD
Medlosar-Plus 25
Magbro Healthcare Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
de66f13d2fc12bdf
Company
Magbro Healthcare Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
de66f13d2fc12bdf
Drug Approval Philippines Name
Medlosar-Plus 25
Product Name
Medlosar-Plus 25
Registration Number
DR-XY48057
Brand Name
Medlosar-Plus 25
Generic Name
Losartan potassium + Hydrochlorothiazide
Dosage Form
Film-Coated Tablet
Dosage Strength
100mg/25mg
Manufacturer
Magbro Healthcare Pvt. Ltd.
Importer
Teramedix Pharma Trading, Inc.
Distributor
Teramedix Pharma Trading, Inc.
Issuance Date
27 May 2022
Expiry Date
27 May 2027
Pharmacologic Category
Angiotensin II Receptor Blocker (ARB)/Diuretic
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
de66f13d2fc12bdf
Type
Standard
Back to Philippines FDA Approvals